An increase in the expression of Apo1-Fas/CD95 apoptotic marker in myeloid progenitor cells in CLL patients and a corresponding decrease in the apoptotic BCL-2 inhibitor has also been described (12). The gene discussed is FAS; the disease is B-cell chronic lymphocytic leukemia.